Oakland, CA, United States of America

Steven Donald Jacob

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 19.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Inventor Spotlight: Steven Donald Jacob

Introduction: Steven Donald Jacob, based in Oakland, California, is a prominent inventor with a significant contribution to medical science through his innovative research and development. He holds five patents, focusing on compounds that have the potential to treat various diseases, particularly those related to cancer and immune disorders.

Latest Patents: Among his recent patents are two notable innovations. The first patent describes inhibitors of ARG1 and/or ARG2, highlighting compounds that serve as inhibitors for at least one of these enzymes. This groundbreaking work encompasses not only the synthesis methods for these compounds but also their application in treating a wide range of diseases and conditions, particularly those mediated by ARG1 and ARG2. The second patent involves tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α. This patent details how these compounds can inhibit HIF-2α and their potential use in the treatment of various cancer- and immune-related disorders.

Career Highlights: Steven works at Arcus Biosciences, Inc., a company committed to advancing cancer therapies through innovative treatments. His research has contributed significantly to the field, resulting in multiple patents that enhance our understanding and approach to treating complex medical conditions.

Collaborations: Throughout his career, Steven has collaborated with esteemed colleagues, including Joel Worley Beatty and Manmohan Reddy Leleti. These partnerships have fostered an environment of innovation and enhanced the development of breakthrough treatments.

Conclusion: Steven Donald Jacob exemplifies the impact of inventive minds on modern medicine. His patents reflect both his deep understanding of scientific principles and his commitment to addressing critical health challenges. Through his continued work at Arcus Biosciences, Steven is poised to make further contributions to the medical field, particularly in the fight against cancer and immune-related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…